Skip to Primary Navigation

AdvaMed urges changes to RAPID pathway for breakthrough devices

A 3-D photo of many colorful dots or spheres on a white background
Photo: Emanuele Cremaschi/Getty Images

Medtech trade group outlines recs to improve Medicare’s proposed RAPID coverage pathway and accelerate access to FDA-authorized tech.

To improve Medicare beneficiaries’ access to breakthrough medical technologies, AdvaMed is urging the Centers for Medicare & Medicaid Services (CMS) to refine its proposed Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway.

The medical technology industry association said the proposed pathway represents an important step toward creating a

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience